Abstract CT225: AARON: An ongoing open-label phase I/II study of relatlimab (anti-LAG-3) with nivolumab (anti-PD-1) in combination with azacitidine ± venetoclax for the treatment of patients with relapsed/refractory and non-fit patients with newly diagnosed acute myeloid leukemia - Interim analysis
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Veit Buecklein, Giulia Magno, Christian Rausch, Maximilian Warm, Alica-Joana Emhardt, Adrian Gottschlich, Karsten Spiekermann, Christian Schmidt, Sabine Witt, Michael Unterhalt, Naval Daver, Marion Subklewe
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409821773